Targeted delivery of drugs is a major challenge in treatment of diverse diseases. Systemically administered drugs demand high doses and are accompanied by poor selectivity and side effects on non-target cells. In a joint research programme between LNQE, BMWZ at Leibniz Universität Hannover and the Helmholtzzentrum für Infektionsforschung (HZI) in Braunschweig we recently introduced a new principle for targeted drug delivery. It is based on macrophages as transporters for nanoparticle-coupled drugs as well as controlled release of drugs by hyperthermia mediated disruption of the cargo cells and simultaneous deliberation of nanoparticle-linked drugs. Hyperthermia is induced by an alternating electromagnetic field (AMF) that induces heat from silica-coated superparamagnetic iron oxide nanoparticles (SPIONs) (Figure 1) Figure 1: Concept of drug delease from SPIONs by hyperthermia.
We demonstrated the proof-of-principle of controlled release by the simultaneous disruption of the cargo macrophages and the controlled, AMF induced release of a toxin, which was covalently linked to silicacoated SPIONs via a thermo-sensitive linker (Figure 2) . Cells that had not been loaded with SPIONs remain unaffected. Moreover, in a 3D co-culture model we demonstrate specific killing of associated tumor cells when employing a ratio as low as 1:40 (SPION-loaded macrophage : tumor cells). Overall, our results demonstrate that AMF-induced drug release from macrophage-entrapped nanoparticles is tightly controlled and may be an attractive novel strategy for targeted drug release. Using an in vitro tumor model we found elimination of tumors which sets the stage for extending these studies to in vivo investigations.
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